New Triple Combination Therapy Boosts Colorectal Cancer Survival
Pierre Fabre and Array BioPharma's combination therapy for colorectal cancer has improved progression-free survival in…
Pierre Fabre and Array BioPharma's combination therapy for colorectal cancer has improved progression-free survival in…
With its new Fund for Innovation, Pierre Fabre will collaborate with H-Immune to use its 'In Vitro…
ADCs are overcoming the challenges of first generations and returning with a vengeance. I attended the…
Immunocore and Pierre Fabre have been representing Europe in this years' Society for Melanoma Research Congress.…
Over the past decade there has been an unprecedented restructuring of R&D in pharma whereas…
Pierre Fabre has a new partnership for its Open Innovation programme based on an extensive…
This is what Laurent Audoly, Head of R&D of Pierre Fabre, told me at the…
Open Innovation is now everywhere, even Pharma. So, just today in France, the opening of the…
Biotech is getting more and more about partnering rather than doing everything alone. Some conservative…